WILMINGTON, Del., April 21, 2015 /PRNewswire/ --
First Quarter Highlights
- Delivered first-quarter operating earnings per share of
$1.34, which includes a $0.25 per share negative impact from currency in
segment results.
- Delivered volume growth and operating margin improvement in
Performance Materials, Safety & Protection, Nutrition &
Health, and Industrial Biosciences and introduced over 600 new
products in the first quarter, a 5 percent increase from prior
year.
- Sales were $9.2 billion, down
9 percent versus prior year primarily due to impacts from currency
(6 percent), portfolio changes (2 percent) and expected near-term
industry-wide challenges in Agriculture and Performance
Chemicals.
- Cost reductions from operational redesign contributed
$0.10 per share to first-quarter
operating earnings; 2015 total cost savings expected to increase to
approximately $0.40 per
share.
- Estimated negative currency impact in 2015 increased to
approximately $0.80 per share, up
from the $0.60 per share we
previously communicated; Company now expects to be at the low end
of the previously communicated outlook range of $4.00-$4.20 operating earnings per share,
including Performance Chemicals segment.
DuPont (NYSE: DD), a science company that brings world-class,
innovative products, materials, and services to the global
marketplace, today announced first quarter 2015 operating earnings
of $1.34 per share, which includes a
$0.25 per share negative currency
impact, compared to $1.58 per share
in the prior year. GAAP1 earnings were
$1.0 billion, or $1.13 per share, compared to $1.4 billion, or $1.54 per share, in the prior year.
DuPont also announced that its board of directors approved a
second quarter dividend of 49 cents
per share, a 4 percent increase over the 47 cents paid last
quarter. This is the fourth increase since the beginning of
2012. The second quarter dividend of 49 cents per share of common stock is payable on
June 12, 2015 to stockholders of
record at the close of business on May
15, 2015.
"DuPont delivered volume and margin improvements in the majority
of our post-spin segments through intense focus on innovation,
disciplined execution and ongoing efficiency improvements and cost
reduction, even in the midst of challenging currency and market
environments," said Ellen Kullman,
DuPont Chair and CEO. "We expect performance in the remainder
of the year to build on this momentum, driven by new product sales
and benefits from our accelerated operational redesign. We
are also announcing our fourth quarterly dividend increase since
the beginning of 2012, reflecting our confidence in the continued
strength of our ongoing, post-spin business and our ability to
advance our record of stable growth while returning capital to
shareholders."
"2015 is an important year in our transformation. The
spin-off of Chemours is on track for the middle of this year, and
we expect to return to shareholders substantially all of the
approximately $4 billion of one-time
dividend proceeds within 12 to 18 months of the separation, a
portion of which will occur before the end of 2015. Following
the separation, DuPont will be fully focused on three highly
attractive strategic focus areas where our science and engineering
capabilities can deliver the greatest value for shareholders.
We are confident that DuPont will continue its momentum, growing
value for shareholders by leveraging our innovation platform,
focusing intently on operational efficiency and costs, actively
managing our portfolio, and through the disciplined return of
capital."
1Generally
Accepted Accounting Principles (GAAP)
|
Global Consolidated Net Sales – 1st Quarter
|
|
Three Months
Ended
|
|
|
|
|
|
|
|
|
|
|
March 31,
2015
|
|
Percent Change Due
to:
|
|
|
|
|
%
|
|
Local Price
and
|
|
|
|
|
|
Portfolio
/
|
|
|
$
|
|
Change
|
|
Product
Mix
|
|
Currency
|
|
Volume
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in
millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. & Canada
|
|
$ 4,319
|
|
(3)
|
|
(1)
|
|
-
|
|
-
|
|
(2)
|
EMEA *
|
|
2,418
|
|
(18)
|
|
3
|
|
(16)
|
|
(3)
|
|
(2)
|
Asia
Pacific
|
|
1,643
|
|
(6)
|
|
(1)
|
|
(3)
|
|
-
|
|
(2)
|
Latin America
|
|
792
|
|
(18)
|
|
(1)
|
|
(6)
|
|
(9)
|
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Consolidated
Sales
|
|
$ 9,172
|
|
(9)
|
|
-
|
|
(6)
|
|
(1)
|
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Europe,
Middle East & Africa
|
|
|
|
|
|
|
|
|
|
|
Segment Sales – 1st Quarter
|
|
Three Months
Ended
|
|
|
|
|
|
|
|
|
|
|
March 31,
2015
|
|
Percent Change Due
to:
|
|
|
|
|
|
|
Local Price
and
|
|
|
|
|
|
Portfolio
/
|
|
|
$
|
|
% Change
|
|
Product
Mix
|
|
Currency
|
|
Volume
|
|
Other
|
(Dollars in
millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
Agriculture
|
|
$ 3,937
|
|
(10)
|
|
3
|
|
(8)
|
|
(5)
|
|
-
|
Electronics &
Communications
|
521
|
|
(10)
|
|
(5)
|
|
(2)
|
|
(3)
|
|
-
|
Industrial
Biosciences
|
|
285
|
|
(5)
|
|
-
|
|
(6)
|
|
1
|
|
-
|
Nutrition &
Health
|
|
813
|
|
(6)
|
|
-
|
|
(8)
|
|
2
|
|
-
|
Performance
Chemicals
|
1,364
|
|
(14)
|
|
(3)
|
|
(3)
|
|
(6)
|
|
(2)
|
Performance
Materials
|
|
1,411
|
|
(8)
|
|
(3)
|
|
(5)
|
|
8
|
|
(8)
|
Safety &
Protection
|
|
909
|
|
(4)
|
|
(1)
|
|
(4)
|
|
6
|
|
(5)
|
Other
|
|
1
|
|
|
|
|
|
|
|
|
|
|
Total segment
sales
|
|
9,241
|
|
(9)
|
|
-
|
|
(6)
|
|
(1)
|
|
(2)
|
Elimination of
transfers
|
|
(69)
|
|
|
|
|
|
|
|
|
|
|
Consolidated net
sales
|
|
$ 9,172
|
|
|
|
|
|
|
|
|
|
|
Operating Earnings – 1st Quarter
|
|
|
|
|
Change vs.
2014
|
(Dollars in
millions)
|
1Q15
|
|
1Q14
|
|
$
|
|
%
|
Agriculture
|
$ 1,139
|
|
$ 1,442
|
|
$ (303)
|
|
-21%
|
Electronics &
Communications
|
85
|
|
75
|
|
10
|
|
13%
|
Industrial
Biosciences
|
56
|
|
56
|
|
-
|
|
0%
|
Nutrition &
Health
|
89
|
|
93
|
|
(4)
|
|
-4%
|
Performance Chemicals
(1)
|
129
|
|
206
|
|
(77)
|
|
-37%
|
Performance Materials
(1)
|
327
|
|
293
|
|
34
|
|
12%
|
Safety &
Protection
|
184
|
|
175
|
|
9
|
|
5%
|
Other
|
(66)
|
|
(92)
|
|
26
|
|
28%
|
Total segment
operating earnings (2)
|
1,943
|
|
2,248
|
|
(305)
|
|
-14%
|
|
|
|
|
|
|
|
|
Exchange gains
(losses) (2), (3)
|
127
|
|
(96)
|
|
223
|
|
|
Corporate
expenses
|
(164)
|
|
(201)
|
|
37
|
|
|
Interest
expense
|
(84)
|
|
(103)
|
|
19
|
|
|
Operating earnings
before income taxes
|
1,822
|
|
1,848
|
|
(26)
|
|
-1%
|
Provision for income
taxes on operating earnings
|
(590)
|
|
(370)
|
|
(220)
|
|
|
Less: Net income
attributable to noncontrolling interests
|
4
|
|
6
|
|
(2)
|
|
|
Operating
earnings
|
$ 1,228
|
|
$ 1,472
|
|
$ (244)
|
|
-17%
|
|
|
|
|
|
|
|
|
Operating earnings
per share
|
$ 1.34
|
|
$ 1.58
|
|
$ (0.24)
|
|
-15%
|
|
(1) Prior period
reflects the reclassifications of the Viton® fluoroelastomer
product line from Performance Materials to Performance
Chemicals.
|
(2) See Schedules B
and C for listing of significant items and their impact by
segment.
|
(3) See Schedule D
for additional information on exchange gains and losses.
|
The following is a summary of business results for each of the
company's reportable segments comparing first quarter with the
prior year, unless otherwise noted.
Agriculture – Operating earnings of $1,139 million decreased $303 million, or 21 percent, as improved product
mix in Pioneer, pricing actions taken in parts of Europe and Asia and productivity improvements were more
than offset by the negative impact of currency, decreased volumes
from expected reduction in global corn planted area, lower
insecticide demand in Latin
America and timing of seed shipments.
Electronics & Communications – Operating
earnings of $85 million increased
$10 million, or 13 percent, driven by
increased demand in consumer electronics and productivity gains
which were partially offset by competitive pressures impacting
Solamet® paste and the negative impact of currency.
Industrial Biosciences – Operating earnings of
$56 million were even with prior year
as increased enzyme demand, principally in food markets, was offset
by the negative impact of currency and lower biomaterials
sales.
Nutrition & Health – Operating earnings of
$89 million decreased $4 million, or 4 percent, as volume gains and
improved product mix were more than offset by the negative impact
of currency.
Performance Chemicals – Operating earnings of
$129 million decreased $77 million, or 37 percent, driven by lower
prices and volumes for titanium dioxide, and the negative impact of
currency.
Performance Materials – Operating earnings of
$327 million increased $34 million, or 12 percent, driven by volume
growth for ethylene and improved product mix, partially offset by
lower ethylene prices and the negative impact of currency. Prior
year ethylene sales were constrained in advance of a scheduled
outage at the Orange, Texas
ethylene unit.
Safety & Protection – Operating earnings of
$184 million increased $9 million, or 5 percent, on broad-based volume
growth in global industrial markets, continued strong public sector
demand in Europe and productivity
improvements partially offset by the negative impact of
currency. Higher costs associated with lower plant
utilization at the Chambers Works facility were largely offset by a
benefit in connection with the advancement of an ongoing claim.
Outlook
Given the continued strengthening of the U.S. dollar relative to
an average basket of exchange rates for our business for the week
beginning April 13th, the company now
estimates an approximately $0.80 per
share negative currency impact in 2015, up from the $0.60 per share the Company estimated on
January 23rd. The
company also now anticipates that the operational redesign will
deliver savings of approximately $0.40 per share in 2015. As a result, the
company expects to be at the low end of its previously communicated
outlook range of $4.00-$4.20
operating earnings per share for 2015, including the full year
outlook for the Performance Chemicals segment.
The 2015 outlook does not reflect the planned separation of the
Performance Chemicals segment or the impact of the expected return
of capital related to the separation.
DuPont will hold a conference call and webcast on Tuesday, April 21, 2015, at 9:00 AM EDT to discuss this news release.
The webcast and additional presentation materials can be accessed
by visiting the company's investor website (Events &
Presentations) at www.investors.dupont.com. A replay of the
conference call webcast will be available for 90 days by calling
1-630-652-3042, Passcode 38251527#. For additional
information see the investor center at http://www.dupont.com.
Use of Non-GAAP Measures
Management believes that certain non-GAAP measurements are
meaningful to investors because they provide insight with respect
to ongoing operating results of the company. Such
measurements are not recognized in accordance with GAAP and should
not be viewed as an alternative to GAAP measures of
performance. Reconciliations of non-GAAP measures to GAAP are
provided in schedules A, C and D.
About DuPont
DuPont (NYSE: DD) has been bringing world-class science and
engineering to the global marketplace in the form of innovative
products, materials, and services since 1802. The company
believes that by collaborating with customers, governments, NGOs,
and thought leaders we can help find solutions to such global
challenges as providing enough healthy food for people everywhere,
decreasing dependence on fossil fuels, and protecting life and the
environment. For additional information about DuPont and its
commitment to inclusive innovation, please visit
http://www.dupont.com.
Forward Looking Statements: This document contains
forward-looking statements which may be identified by their use of
words like "plans," "expects," "will," "believes," "intends,"
"estimates," "anticipates" or other words of similar meaning. All
statements that address expectations or projections about the
future, including statements about the company's strategy for
growth, product development, regulatory approval, market position,
anticipated benefits of recent acquisitions, timing of anticipated
benefits from restructuring actions, outcome of contingencies, such
as litigation and environmental matters, expenditures and financial
results, are forward looking statements. Forward-looking statements
are not guarantees of future performance and are based on certain
assumptions and expectations of future events which may not be
realized. Forward-looking statements also involve risks and
uncertainties, many of which are beyond the company's control. Some
of the important factors that could cause the company's actual
results to differ materially from those projected in any such
forward-looking statements are: fluctuations in energy and raw
material prices; failure to develop and market new products and
optimally manage product life cycles; ability to respond to market
acceptance, rules, regulations and policies affecting products
based on biotechnology; significant litigation and environmental
matters; failure to appropriately manage process safety and product
stewardship issues; changes in laws and regulations or political
conditions; global economic and capital markets conditions, such as
inflation, interest and currency exchange rates; business or supply
disruptions; security threats, such as acts of sabotage, terrorism
or war, weather events and natural disasters; ability to protect
and enforce the company's intellectual property rights; successful
integration of acquired businesses and separation of
underperforming or non-strategic assets or businesses and
successful completion of the proposed spinoff of the Performance
Chemicals segment including ability to fully realize the expected
benefits of the proposed spinoff. The company undertakes no duty to
update any forward-looking statements as a result of future
developments or new information.
E.I. du Pont de
Nemours and Company
Consolidated Income
Statements
(Dollars in
millions, except per share amounts)
|
|
SCHEDULE
A
|
|
|
|
|
Three Months
Ended
March
31,
|
|
2015
|
|
2014
|
Net sales
|
$
|
9,172
|
|
|
$
|
10,128
|
|
Other income, net
(1)
|
198
|
|
|
17
|
|
Total
|
9,370
|
|
|
10,145
|
|
|
|
|
|
Cost of goods
sold
|
5,553
|
|
|
6,000
|
|
Other operating
charges (1)
|
283
|
|
|
286
|
|
Selling, general and
administrative expenses
|
1,312
|
|
|
1,436
|
|
Research and
development expense
|
499
|
|
|
518
|
|
Interest
expense
|
84
|
|
|
103
|
|
Employee separation /
asset related charges, net (1)
|
38
|
|
|
—
|
|
Total
|
7,769
|
|
|
8,343
|
|
|
|
|
|
Income before income
taxes
|
1,601
|
|
|
1,802
|
|
Provision for income
taxes (1)
|
566
|
|
|
357
|
|
Net income
|
1,035
|
|
|
1,445
|
|
|
|
|
|
Less: Net
income attributable to noncontrolling interests
|
4
|
|
|
6
|
|
|
|
|
|
Net income
attributable to DuPont
|
$
|
1,031
|
|
|
$
|
1,439
|
|
|
|
|
|
Basic earnings per
share of common stock
|
$
|
1.13
|
|
|
$
|
1.56
|
|
|
|
|
|
Diluted earnings per
share of common stock
|
$
|
1.13
|
|
|
$
|
1.54
|
|
|
|
|
|
Dividends per share
of common stock
|
$
|
0.47
|
|
|
$
|
0.45
|
|
|
|
|
|
Average number of
shares outstanding used in earnings per share (EPS)
calculation:
|
|
|
|
Basic
|
906,835,000
|
|
|
923,461,000
|
|
Diluted
|
913,819,000
|
|
|
930,732,000
|
|
Reconciliation of
Non-GAAP Measures
|
Summary of
Earnings Comparison
|
|
Three Months
Ended
March
31,
|
|
2015
|
|
2014
|
|
%
Change
|
Net income
(GAAP)
|
$
|
1,035
|
|
|
$
|
1,445
|
|
|
(28)%
|
|
Less: Significant
items charge (benefit), after-tax, included in net income (per
Schedule B)
|
(126)
|
|
|
(12)
|
|
|
|
Non-operating
pension/OPEB costs, after-tax, included in net income
(2)
|
(71)
|
|
|
(21)
|
|
|
|
Net income
attributable to noncontrolling interest
|
4
|
|
|
6
|
|
|
|
Operating earnings
(Non-GAAP)
|
$
|
1,228
|
|
|
$
|
1,472
|
|
|
(17)%
|
|
|
|
|
|
|
|
EPS attributable to
DuPont (GAAP)
|
$
|
1.13
|
|
|
$
|
1.54
|
|
|
(27)%
|
|
Significant items
charge (benefit) included in EPS (per Schedule B)
|
(0.14)
|
|
|
(0.01)
|
|
|
|
Non-operating
pension/OPEB costs included in EPS (2)
|
(0.07)
|
|
|
(0.03)
|
|
|
|
Operating EPS
(Non-GAAP)
|
$
|
1.34
|
|
|
$
|
1.58
|
|
|
(15)%
|
|
E.I. du Pont de
Nemours and Company
Condensed
Consolidated Balance Sheets
(Dollars in
millions, except per share amounts)
|
|
SCHEDULE A
(continued)
|
|
|
|
|
March
31,
2015
|
|
December
31,
2014
|
Assets
|
|
|
|
|
Current
assets
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
3,622
|
|
|
$
|
6,910
|
|
Marketable
securities
|
|
125
|
|
|
124
|
|
Accounts and notes
receivable, net
|
|
7,651
|
|
|
6,005
|
|
Inventories
|
|
7,051
|
|
|
7,841
|
|
Prepaid
expenses
|
|
366
|
|
|
279
|
|
Deferred income
taxes
|
|
504
|
|
|
589
|
|
Total current
assets
|
|
19,319
|
|
|
21,748
|
|
Property, plant
and equipment, net of accumulated depreciation
(March
31, 2015- $20,057; December 31, 2014 - $19,942)
|
|
12,873
|
|
|
13,386
|
|
Goodwill
|
|
4,365
|
|
|
4,529
|
|
Other intangible
assets
|
|
4,307
|
|
|
4,580
|
|
Investment in
affiliates
|
|
929
|
|
|
886
|
|
Deferred income
taxes
|
|
3,244
|
|
|
3,349
|
|
Other
assets
|
|
1,138
|
|
|
1,096
|
|
Total
|
|
$
|
46,175
|
|
|
$
|
49,574
|
|
|
|
|
|
|
Liabilities and
Equity
|
|
|
|
|
Current
liabilities
|
|
|
|
|
Accounts
payable
|
|
$
|
3,706
|
|
|
$
|
4,822
|
|
Short-term borrowings
and capital lease obligations
|
|
1,621
|
|
|
1,423
|
|
Income
taxes
|
|
654
|
|
|
547
|
|
Other accrued
liabilities
|
|
4,751
|
|
|
5,848
|
|
Total current
liabilities
|
|
10,732
|
|
|
12,640
|
|
Long-term
borrowings and capital lease obligations
|
|
8,763
|
|
|
9,271
|
|
Other
liabilities
|
|
13,329
|
|
|
13,819
|
|
Deferred income
taxes
|
|
489
|
|
|
466
|
|
Total
liabilities
|
|
33,313
|
|
|
36,196
|
|
|
|
|
|
|
Commitments and
contingent liabilities
|
|
|
|
|
|
|
|
|
|
Stockholders'
equity
|
|
|
|
|
Preferred
stock
|
|
237
|
|
|
237
|
|
Common stock, $0.30
par value; 1,800,000,000 shares authorized;
Issued
at March 31, 2015 - 992,224,000; December 31, 2014 -
992,020,000
|
|
298
|
|
|
298
|
|
Additional paid-in
capital
|
|
11,311
|
|
|
11,174
|
|
Reinvested
earnings
|
|
17,405
|
|
|
17,045
|
|
Accumulated other
comprehensive loss
|
|
(9,722)
|
|
|
(8,707)
|
|
Common stock held in
treasury, at cost (87,041,000 shares at March 31, 2015 and December
31, 2014)
|
|
(6,727)
|
|
|
(6,727)
|
|
Total DuPont
stockholders' equity
|
|
12,802
|
|
|
13,320
|
|
Noncontrolling
interests
|
|
60
|
|
|
58
|
|
Total
equity
|
|
12,862
|
|
|
13,378
|
|
Total
|
|
$
|
46,175
|
|
|
$
|
49,574
|
|
E.I. du Pont de
Nemours and Company
Condensed
Consolidated Statement of Cash Flows
(Dollars in
millions)
|
|
SCHEDULE A
(continued)
|
|
|
Three Months
Ended
March
31,
|
|
2015
|
|
2014
|
Total
Company
|
|
|
|
Net income
|
$
|
1,035
|
|
|
$
|
1,445
|
|
Adjustments to
reconcile net income to cash used for operating
activities:
|
|
|
|
Depreciation
|
306
|
|
|
312
|
|
Amortization of
intangible assets
|
140
|
|
|
125
|
|
Net periodic pension
benefit cost
|
147
|
|
|
100
|
|
Contributions to
pension plans
|
(124)
|
|
|
(101)
|
|
Other operating
activities - net
|
(2)
|
|
|
212
|
|
Change in operating
assets and liabilities - net
|
(3,625)
|
|
|
(4,514)
|
|
Cash used for
operating activities
|
(2,123)
|
|
|
(2,421)
|
|
|
|
|
|
Investing
activities
|
|
|
|
Purchases of
property, plant and equipment
|
(565)
|
|
|
(320)
|
|
Investments in
affiliates
|
(45)
|
|
|
(22)
|
|
Proceeds from sales
of businesses - net
|
16
|
|
|
—
|
|
Proceeds from sales
of assets - net
|
9
|
|
|
7
|
|
Net decrease in
short-term financial instruments
|
—
|
|
|
80
|
|
Foreign currency
exchange contract settlements
|
442
|
|
|
15
|
|
Other investing
activities - net
|
3
|
|
|
4
|
|
Cash used for
investing activities
|
(140)
|
|
|
(236)
|
|
|
|
|
|
Financing
activities
|
|
|
|
Dividends paid to
stockholders
|
(429)
|
|
|
(420)
|
|
Net decrease in
borrowings
|
(309)
|
|
|
(1,127)
|
|
Repurchase /
prepayments of common stock
|
(282)
|
|
|
(1,061)
|
|
Proceeds from
exercise of stock options
|
170
|
|
|
153
|
|
Other financing
activities - net
|
(1)
|
|
|
(14)
|
|
Cash used for
financing activities
|
(851)
|
|
|
(2,469)
|
|
|
|
|
|
Effect of exchange
rate changes on cash
|
(174)
|
|
|
(33)
|
|
|
|
|
|
Decrease in cash
and cash equivalents
|
(3,288)
|
|
|
(5,159)
|
|
|
|
|
|
Cash and cash
equivalents at beginning of period
|
6,910
|
|
|
8,941
|
|
|
|
|
|
Cash and cash
equivalents at end of period
|
$
|
3,622
|
|
|
$
|
3,782
|
|
|
|
|
|
Reconciliation of
Non-GAAP Measure
|
|
|
|
Calculation of
Free Cash Flow - Total Company
|
|
|
|
|
Three Months
Ended
March
31,
|
|
2015
|
|
2014
|
Cash used for
operating activities
|
$
|
(2,123)
|
|
|
$
|
(2,421)
|
|
Purchases of
property, plant and equipment
|
(565)
|
|
|
(320)
|
|
Free cash
flow
|
$
|
(2,688)
|
|
|
$
|
(2,741)
|
|
|
|
|
|
(1) See
Schedule B for detail of significant items.
|
(2) First
quarter 2015 includes the impact of an after-tax exchange loss on
non-operating pension of $23.
|
E.I. du Pont de
Nemours and Company
Schedule of
Significant Items
(Dollars in
millions, except per share amounts)
|
|
SCHEDULE
B
|
SIGNIFICANT
ITEMS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-tax
|
|
After-tax
|
|
($ Per
Share)
|
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
1st
Quarter
|
|
|
|
|
|
|
|
|
|
|
|
Separation
transaction costs (1)
|
$
|
(81)
|
|
|
$
|
(16)
|
|
|
$
|
(80)
|
|
|
$
|
(12)
|
|
|
$
|
(0.09)
|
|
|
$
|
(0.01)
|
|
Customer claims
recovery (2)
|
35
|
|
|
—
|
|
|
22
|
|
|
—
|
|
|
0.02
|
|
|
—
|
|
Asset impairment
charge (3)
|
(37)
|
|
|
—
|
|
|
(30)
|
|
|
—
|
|
|
(0.03)
|
|
|
—
|
|
Ukraine devaluation
(4)
|
(40)
|
|
|
—
|
|
|
(38)
|
|
|
—
|
|
|
(0.04)
|
|
|
—
|
|
1st Quarter -
Total
|
$
|
(123)
|
|
|
$
|
(16)
|
|
|
$
|
(126)
|
|
|
$
|
(12)
|
|
|
$
|
(0.14)
|
|
|
$
|
(0.01)
|
|
(1)
|
First quarter 2015
and 2014 included charges of $(81) and $(16), respectively recorded
in other operating charges associated with transaction costs
related to the separation of the Performance Chemicals
segment.
|
|
|
(2)
|
The company recorded
insurance recoveries of $35 in other operating charges, in the
first quarter 2015 in the Agriculture segment, for recovery of
costs for customer claims related to the use of the
Imprelis® herbicide. The company had accruals of $231
related to these customer claims at March 31, 2015. The company has
submitted and will continue to submit requests for payment to its
insurance carriers for costs associated with this matter. To date,
the company has recognized $318 of insurance recoveries from its
insurance carriers and continues to seek recovery although the
timing and outcome remain uncertain.
|
|
|
(3)
|
During first quarter
of 2015, a $(37) pre-tax impairment charge was recorded
in employee separation / asset related charges, net for a cost
basis investment within the Other segment. The assessment
resulted from the venture's revised operating plan reflecting
underperformance of its European wheat based ethanol facility and
deteriorating European ethanol market conditions. One of the
primary investors has communicated they would not fund the revised
operating plan of the investee. As a result, the carrying
value of our 6% equity investment in this venture exceeds its
fair value.
|
|
|
(4)
|
First quarter 2015
included a charge of $(40) in other income, net associated with
remeasuring the company's Ukrainian hryvnia net monetary assets.
Ukraine's central bank adopted a decision to no longer set the
indicative hryvnia exchange rate. The hryvnia became a
free-floating exchange rate and lost approximately a third of its
value through the quarter.
|
E.I. du Pont de
Nemours and Company
Consolidated Segment
Information
(Dollars in
millions)
|
|
SCHEDULE
C
|
|
|
|
|
Three Months
Ended
March
31,
|
SEGMENT SALES
(1)
|
2015
|
|
2014
|
Agriculture
|
$
|
3,937
|
|
|
$
|
4,394
|
|
Electronics &
Communications
|
521
|
|
|
580
|
|
Industrial
Biosciences
|
285
|
|
|
301
|
|
Nutrition & Health
|
813
|
|
|
861
|
|
Performance Chemicals
(2)
|
1,364
|
|
|
1,591
|
|
Performance Materials
(2)
|
1,411
|
|
|
1,534
|
|
Safety &
Protection
|
909
|
|
|
947
|
|
Other
|
1
|
|
|
1
|
|
Total Segment
sales
|
9,241
|
|
|
10,209
|
|
|
|
|
|
Elimination of
transfers
|
(69)
|
|
|
(81)
|
|
Consolidated net
sales
|
$
|
9,172
|
|
|
$
|
10,128
|
|
E.I. du Pont de
Nemours and Company
Consolidated Segment
Information
(Dollars in
millions)
|
|
SCHEDULE C
(continued)
|
|
|
|
|
|
|
Three Months
Ended
March
31,
|
INCOME BEFORE INCOME
TAXES (GAAP)
|
2015
|
|
2014
|
Agriculture
|
|
$
|
1,174
|
|
|
$
|
1,442
|
|
Electronics &
Communications
|
|
85
|
|
|
75
|
|
Industrial
Biosciences
|
|
56
|
|
|
56
|
|
Nutrition &
Health
|
|
89
|
|
|
93
|
|
Performance Chemicals
(2)
|
|
129
|
|
|
206
|
|
Performance Materials
(2)
|
|
327
|
|
|
293
|
|
Safety &
Protection
|
|
184
|
|
|
175
|
|
Other
|
|
(103)
|
|
|
(92)
|
|
Total Segment
PTOI
|
|
1,941
|
|
|
2,248
|
|
Corporate
expenses
|
|
(245)
|
|
|
(217)
|
|
Interest
expense
|
|
(84)
|
|
|
(103)
|
|
Non-operating
pension/OPEB costs
|
|
(75)
|
|
|
(30)
|
|
Net exchange gains
(losses)
|
|
64
|
|
|
(96)
|
|
Income before income
taxes
|
|
$
|
1,601
|
|
|
$
|
1,802
|
|
|
|
|
|
|
|
|
Three Months
Ended
March
31,
|
SIGNIFICANT ITEMS BY
SEGMENT (PRE-TAX) (4)
|
|
2015
|
|
2014
|
Agriculture
|
|
$
|
35
|
|
|
$
|
—
|
|
Electronics &
Communications
|
|
—
|
|
|
—
|
|
Industrial
Biosciences
|
|
—
|
|
|
—
|
|
Nutrition &
Health
|
|
—
|
|
|
—
|
|
Performance Chemicals
(2)
|
|
—
|
|
|
—
|
|
Performance Materials
(2)
|
|
—
|
|
|
—
|
|
Safety &
Protection
|
|
—
|
|
|
—
|
|
Other
|
|
(37)
|
|
|
—
|
|
Total significant
items by segment
|
|
(2)
|
|
|
—
|
|
Corporate
expenses
|
|
(81)
|
|
|
(16)
|
|
Net exchange gains
(losses)
|
|
(40)
|
|
|
—
|
|
Total significant
items before income taxes
|
|
$
|
(123)
|
|
|
$
|
(16)
|
|
|
|
|
|
|
|
|
Three Months
Ended
March
31,
|
OPERATING EARNINGS
(NON-GAAP)
|
|
2015
|
|
2014
|
Agriculture
|
|
$
|
1,139
|
|
|
$
|
1,442
|
|
Electronics &
Communications
|
|
85
|
|
|
75
|
|
Industrial
Biosciences
|
|
56
|
|
|
56
|
|
Nutrition &
Health
|
|
89
|
|
|
93
|
|
Performance Chemicals
(2)
|
|
129
|
|
|
206
|
|
Performance Materials
(2)
|
|
327
|
|
|
293
|
|
Safety &
Protection
|
|
184
|
|
|
175
|
|
Other
|
|
(66)
|
|
|
(92)
|
|
Total segment
operating earnings
|
|
1,943
|
|
|
2,248
|
|
Corporate
expenses
|
|
(164)
|
|
|
(201)
|
|
Interest
expense
|
|
(84)
|
|
|
(103)
|
|
Operating earnings
before income taxes and exchange gains (losses)
|
|
1,695
|
|
|
1,944
|
|
Net exchange gains
(losses) (3)
|
|
127
|
|
|
(96)
|
|
Operating earnings
before income taxes
|
|
$
|
1,822
|
|
|
$
|
1,848
|
|
|
|
|
|
|
(1)
Segment sales include transfers.
|
(2)
Prior periods reflect the reclassifications of the
Viton® product line from Performance Materials to
Performance Chemicals.
|
(3)
See Schedule D for additional information on exchange gains and
losses. First quarter 2015 exchange gains, on an operating
earnings basis (Non-GAAP), excludes the impact
of a $23 exchange loss on non-operating
pension.
|
(4)
See Schedule B for detail of significant items.
|
E.I. du Pont de
Nemours and Company
Reconciliation of
Non-GAAP Measures
(Dollars in
millions, except per share amounts)
|
|
SCHEDULE
D
|
|
|
|
|
|
Reconciliations of
Adjusted EBIT / EBITDA to Consolidated Income
Statements
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
March
31,
|
|
|
|
2015
|
|
2014
|
Income before income
taxes
|
|
$
|
1,601
|
|
|
$
|
1,802
|
|
Add: Significant
items before income taxes
|
|
123
|
|
|
16
|
|
Add: Non-operating
pension/OPEB costs(1)
|
|
98
|
|
|
30
|
|
Operating earnings
before income taxes
|
|
$
|
1,822
|
|
|
$
|
1,848
|
|
Less: Net income
attributable to noncontrolling interests
|
|
4
|
|
|
6
|
|
Add: Interest
expense
|
|
|
84
|
|
|
103
|
|
Adjusted EBIT from
operating earnings
|
|
1,902
|
|
|
1,945
|
|
Add: Depreciation and
amortization
|
|
446
|
|
|
437
|
|
Adjusted EBITDA from
operating earnings
|
|
$
|
2,348
|
|
|
$
|
2,382
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of
Operating Earnings Per Share (EPS) Outlook
|
The reconciliation
below represents the company's outlook on an operating earnings
basis, defined as earnings excluding significant items and
non-operating pension/OPEB costs.
|
|
|
|
|
|
|
|
|
|
Year Ended
December 31,
|
|
|
|
2015
Outlook
|
|
2014
Actual
|
Operating EPS
(Non-GAAP)
|
|
|
$4.00-$4.20
|
|
$
|
4.01
|
|
|
|
|
|
|
|
Significant
items
|
|
|
|
|
|
Separation
transaction costs
|
|
|
(0.30)
|
|
|
(0.14)
|
|
Gain on sale of
business
|
|
|
|
|
0.47
|
|
Restructuring
charge
|
|
|
|
|
(0.42)
|
|
Venezuela
devaluation
|
|
|
|
|
(0.06)
|
|
Tax items
|
|
|
|
|
—
|
|
Customer claims
recovery
|
|
|
0.02
|
|
|
0.14
|
|
Restructuring
charge/adjustments
|
|
|
|
—
|
|
Litigation
settlement
|
|
|
|
|
—
|
|
Asset impairment
charge
|
|
|
(0.03)
|
|
|
—
|
|
Ukraine
devaluation
|
|
|
(0.04)
|
|
|
—
|
|
|
|
|
|
|
|
Non-operating
pension/OPEB costs - estimate
|
|
|
(0.21)
|
|
|
(0.10)
|
|
|
|
|
|
|
|
EPS (GAAP)
|
|
|
$3.44-$3.64
|
|
$
|
3.90
|
|
|
|
|
|
|
|
E.I. du Pont de
Nemours and Company
Reconciliation of
Non-GAAP Measures
(Dollars in
millions, except per share amounts)
|
|
SCHEDULE D
(continued)
|
|
|
|
|
|
|
|
|
|
Exchange
Gains/Losses on Operating Earnings(2)
|
The company routinely
uses forward exchange contracts to offset its net exposures, by
currency, related to the foreign currency denominated monetary
assets and liabilities of its operations. The objective of this
program is to maintain an approximately balanced position in
foreign currencies in order to minimize, on an after-tax basis, the
effects of exchange rate changes. The net pre-tax exchange gains
and losses are recorded in other income, net and the related tax
impact is recorded in provision for (benefit from) income taxes on
the Consolidated Income Statements.
|
|
|
|
|
|
|
|
Three Months
Ended
March
31,
|
|
|
2015
|
|
2014
|
Subsidiary
Monetary Position Gain (Loss)
|
|
|
|
|
Pre-tax exchange
losses
|
|
$
|
(120)
|
|
|
$
|
(50)
|
|
Local tax (expenses)
benefits
|
|
(123)
|
|
|
12
|
|
Net after-tax impact
from subsidiary exchange losses
|
|
$
|
(243)
|
|
|
$
|
(38)
|
|
|
|
|
|
|
Hedging Program
Gain (Loss)
|
|
|
|
|
Pre-tax exchange
gains (losses)
|
|
$
|
247
|
|
|
$
|
(46)
|
|
Tax (expenses)
benefits
|
|
(89)
|
|
|
16
|
|
Net after-tax impact
from hedging program exchange gains (losses)
|
|
$
|
158
|
|
|
$
|
(30)
|
|
|
|
|
|
|
Total Exchange
Gain (Loss)
|
|
|
|
|
Pre-tax exchange
gains (losses) (3)
|
|
$
|
127
|
|
|
$
|
(96)
|
|
Tax (expenses)
benefits
|
|
(212)
|
|
|
28
|
|
Net after-tax
exchange losses
|
|
$
|
(85)
|
|
|
$
|
(68)
|
|
|
|
|
|
|
As shown above, the
"Total Exchange Gain (Loss)" is the sum of the "Subsidiary Monetary
Position Gain (Loss)" and the "Hedging Program Gain
(Loss)."
|
|
|
|
|
|
Reconciliation of
Base Income Tax Rate to Effective Income Tax Rate
|
Base income tax rate
is defined as the effective income tax rate less the effect of
exchange gains (losses), as defined above, significant items and
non-operating pension/OPEB costs.
|
|
|
|
|
|
|
|
Three Months
Ended
March
31,
|
|
|
2015
|
|
2014
|
Income before income
taxes
|
|
$
|
1,601
|
|
|
$
|
1,802
|
|
Add:
Significant items - charge (2)
|
|
123
|
|
|
16
|
|
Non-operating pension/OPEB costs
|
|
98
|
|
|
30
|
|
Less: Net
exchange gains (losses)
|
|
127
|
|
|
(96)
|
|
Income before income
taxes, significant items,
|
|
|
|
|
exchange gains (losses), and non-operating pension/OPEB
costs
|
|
$
|
1,695
|
|
|
$
|
1,944
|
|
|
|
|
|
|
Provision for income
taxes
|
|
$
|
566
|
|
|
$
|
357
|
|
Add: Tax
(expenses) benefits on significant items
|
|
(3)
|
|
|
4
|
|
Tax benefits on non-operating pension/OPEB costs
|
|
27
|
|
|
9
|
|
Tax (expenses) benefits on exchange gains/losses
|
|
(212)
|
|
|
28
|
|
Provision for income
taxes on operating earnings, excluding exchange gains
(losses)
|
|
$
|
378
|
|
|
$
|
398
|
|
|
|
|
|
|
Effective income tax
rate
|
|
35.4
|
%
|
|
19.8
|
%
|
Significant items
effect and non-operating pension/OPEB costs effect
|
|
(3.0)%
|
|
|
0.2
|
%
|
Tax rate, before
significant items and non-operating pension/OPEB costs
|
|
32.4
|
%
|
|
20.0
|
%
|
Exchange gains
(losses) effect
|
|
(10.1)%
|
|
|
0.5
|
%
|
Base income tax
rate
|
|
22.3
|
%
|
|
20.5
|
%
|
|
|
|
|
|
(1) First
quarter, 2015, non-operating pension/OPEB costs includes a $23
exchange loss on foreign pension balances.
|
(2)
See Schedule B for detail of significant items.
|
(3) First
quarter 2015 exchange gains, on an operating earnings basis
(Non-GAAP), excludes a $23 exchange loss on non-operating
pension.
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/dupont-reports-1q-operating-eps-of-134-300068881.html
SOURCE DuPont